trial · primary record
Hypofractionated Postoperative Radiotherapy
Head and Neck Cancer
| Phase | Phase 1 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 14 |
| Primary completion | 2028-11 |
| Primary endpoint | Dose-Limiting Toxicity (DLT) |
| Registry ID | NCT05540899 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T13:40:30.800Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05540899
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.